Durable remission after allogeneic transplantation despite residual blood disease in Sézary syndrome

Q: What does this research mean for the field?

Allogeneic hematopoietic stem cell transplantation can result in durable remission in patients with Sézary syndrome despite the presence of residual blood disease. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

J. Delaleu; Adielle Abecassis; Victoria Volpari; Maxime Battistella; Hélène Moins‐Teisserenc; Gilles Battesti; Maëlle Dumont; Alizée Bozonnat; Baptiste Louveau; Fanélie Jouenne; Maxence Mancini; Samia Mourah; Maxime Mouthon; M. Bagot; Regis Peffault de la Tour; Jean‐David Bouaziz; Adèle de Masson; Caroline Ram‐Wolff

doi:10.1111/jdv.70674

Key Points

To assess clinical outcomes and long-term remission durability following allogeneic hematopoietic cell transplantation in patients with Sézary syndrome displaying residual blood disease.
Evaluated patients with Sézary syndrome who underwent allogeneic stem cell transplantation.
Monitored post-transplant clinical remission alongside the persistence of measurable residual malignant cells in peripheral blood.
Allogeneic transplantation achieved durable and sustained disease remission in patients with Sézary syndrome.
Long-term disease control was maintained despite the presence of detectable residual blood disease post-transplant.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Clinical study shows durable remission after allogeneic stem cell transplantation despite residual blood disease in Sézary syndrome, suggesting sustained graft-mediated disease control.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Delaleu et al. (2026) studied this question.

synapsesocial.com/papers/6a895eaeca7ade938187cd56 https://doi.org/10.1111/jdv.70674

View at Publisher

Ask AI

Bookmark

Share

Durable remission after allogeneic transplantation despite residual blood disease in Sézary syndrome

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Durable remission after allogeneic transplantation despite residual blood disease in Sézary syndrome

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Keep reading

Keep reading